HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients (Q39844024)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients |
scientific article |
Statements
1 reference
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients (English)
1 reference
Charles J Yeo
1 reference
Nathan G Richards
1 reference
David W Rittenhouse
1 reference
Boris Freydin
1 reference
Joseph A Cozzitorto
1 reference
Dane Grenda
1 reference
Hallgeir Rui
1 reference
Greg Gonye
1 reference
Eugene P Kennedy
1 reference
Jonathan R Brody
1 reference
Agnieszka K Witkiewicz
1 reference
1 September 2010
1 reference
1 reference
252
1 reference
3
1 reference
499-505; discussion 505-6
1 reference
Identifiers
1 reference
1 reference